Company Analysis CSL Limited
1. Summary
Advantages
- Current debt level 32.04% is below 100% and has decreased over 5 years from 37.68%.
- The company's current efficiency (ROE=15.94%) is higher than the sector average (ROE=12.15%)
Disadvantages
- Price (79.75 $) is higher than fair price (32.52 $)
- Dividends (1.41%) are below the sector average (2.17%).
- The stock's return over the last year (-14.68%) is lower than the sector average (3.16%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| CSL Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 1.6% | -0.9% | 1.1% |
| 90 days | -3.8% | -2.8% | 9.1% |
| 1 year | -14.7% | 3.2% | 12.4% |
CSLLY vs Sector: CSL Limited has significantly underperformed the "Healthcare" sector by -17.84% over the past year.
CSLLY vs Market: CSL Limited has significantly underperformed the market by -27.03% over the past year.
Stable price: CSLLY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CSLLY with weekly volatility of -0.2823% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (79.75 $) is higher than the fair price (32.52 $).
Price is higher than fair: The current price (79.75 $) is 59.2% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (35.68) is lower than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (35.68) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.86) is higher than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (4.86) is higher than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (6.42) is higher than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (6.42) is higher than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (22.14) is higher than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (22.14) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 5.13% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (5.13%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (15.94%) is higher than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (15.94%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (7.11%) is higher than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (7.11%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (15.5%) is higher than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (15.5%) is higher than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.41% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.41% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 1.41% has been growing over the last 5 years. Growth over 13 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.92%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
